Brusatol, an NRF2 inhibitor for future cancer therapeutic.
Sabrina J CaiYang LiuSue HanChunzhang YangPublished in: Cell & bioscience (2019)
In conclusion, we believe increasing evidences have shown the value of brusatol as a novel strategy for cancer treatment, which may indicate future drug development and clinical translation.